Biofast

Biofast Technology has currently developed into a composite materials application company. In recent years, it has successfully developed environmentally friendly materials that completely decompose plant starch, as well as 3D multi-layer high-protection masks, while providing a wide range of services including OEM, customization, and brand packaging.

Biomdcare Corporation

AIXA: Fast & Accurate AI Bone Health Assessment

AIXA leverages AI-powered imaging analysis to evaluate bone density and muscle mass in just 6 seconds using standard chest X-rays. It detects risks of osteoporosis, sarcopenia, and compression fractures with accuracy comparable to DXA (CCC = 0.996), sensitivity of 97.2%, and specificity of 95.6%.

Without requiring additional equipment, AIXA transforms routine X-rays into actionable diagnostics, enabling early intervention and large-scale screening. It offers a cost-effective solution for hospitals, clinics, and long-term care centers—whether as a DXA alternative, a triage tool for high-risk patients, or as part of mobile X-ray units serving remote areas. AIXA enhances accessibility, efficiency, and clinical decision-making in bone health care.

Biomedica

AIXA uses AI to quickly assess risks of osteoporosis, sarcopenia, and compression fractures, delivering professional reports in just 6 seconds. With DXA-level accuracy (CCC = 0.996), it offers 97.2% sensitivity, 95.6% specificity, and AUC 0.96. By analyzing standard hip and spine X-rays, AIXA provides efficient, low-cost bone and muscle assessments to support clinical decisions and early intervention.

BIONET Therapeutics Corp

BIONIME CORPORATION

Bionime focuses on diabetes care and developed the first domestically approved RIGHTEST iFree Continuous Glucose Monitoring System (CGM). Unlike traditional finger-prick testing, iFree CGM uses a soft sensor inserted under the skin and works with a dedicated app to continuously track glucose for 10 days, allowing users and caregivers to monitor changes in real time while reducing the discomfort of frequent pricks. The second-generation iFree 2 CGM is fully optimized, offering 15-day wear, calibration-free operation, anti-interference performance, and rechargeable reusability. Combining expertise in electronics, biochemistry, software, and smart manufacturing, it integrates over 80 technologies and holds more than 450 patents across multiple countries. Bionime has also implemented over 2,000 quality control procedures and established an Industry 4.0 automated production line, ensuring stable manufacturing and high reliability. Guided by its mission to provide high-quality, affordable CGMs, Bionime strives to make CGM widely accessible and fulfill its vision: Better Health for More People.

BIONIQUE Biology Co., Ltd.

BIONIQUE

BIONIQUE, an independent startup since September 2025 in Hsinchu, Taiwan, develops fast and reliable semiconductor biochip solutions.

Our AttoSense Platform includes disposable biochips, a handheld reader, and an automated analyzer, detecting nucleic acids, proteins, and microorganisms in just 30 minutes.

Awarded the National Innovation Award (2024) and Bronze Medal of the National Pharmaceutical Award (2025), we advance applications in livestock epidemic detection and human health biomarkers. Visit us at Booth L603a to know more.

BiOptic Inc.

Qsep100 2.0 Bio-Fragment Analyzer ushers in a new era of capillary gel electrophoresis, combining patented LEDIF detection with full automation to deliver high-resolution, high-sensitivity, and highly reproducible analysis. Its versatile applications cover DNA, RNA, and protein fragments, empowering research across multiple fields. With ready-to-use cartridges, samples in standard PCR tubes or 96-well plates can be directly placed into the instrument for analysis, enabling preparation and operation within three minutes with flexible control of injection, voltage, and run conditions. The system supports throughput from a single sample up to 96 (expandable to 384-well), offering unmatched scalability and efficiency for modern laboratories.

Biotechnology

ExoBioCARE Biotechnology focuses on the research and application of stem cell technology, dedicated to providing efficient and safe stem cell products for use in medical aesthetics and anti-aging health care.The company has developed multiple advanced technologies and received numerous international awards. Our mission is to utilize cutting-edge technology to enhance people\\\'s quality of life.
ExoBioCARE Biotechnology has an experienced and professional management team. Our General Manager has extensive experience in the biotech industry, and our Technical Director has made outstanding contributions in the field of stem cell research and development.

Our research and development team consists of renowned experts from both domestic and international backgrounds, dedicated to driving continuous technological advancements for the company.
Our operational goal is to become the world\\\'s leading stem cell technology company, focusing on the research and development of cell culture and production equipment and automation solutions, planning and building cell factory production lines, and the development and sales of stem cell secretome products. We are committed to providing the best solutions for the medical beauty and health care fields.

Biyoung Biomedical Technology Co., Ltd.

Biyoung Biotechnology from Taiwan is showcasing the globally leading “High-Concentration Oxygen Dissolving Water Machine”, achieving dissolved oxygen levels up to 50 ppm—approximately 10 times higher than ordinary drinking water.
Its patented technology has been certified in the U.S., China, and Taiwan, and has received 19 gold medals and special awards at international invention fairs.
The product is miniaturized and easy to operate, suitable for households, offices, clinics, and gyms—showcasing high market potential.
Live demonstrations and partnership introductions are available on-site. We sincerely invite distributors and agents to join us in developing the emerging “high-dissolved-oxygen water” market.

BLOSSOM BIOTECHNOLOGIES INC.

Blossom Biotechnologies, Inc., established in July 1998, has over 20 years of experience bringing cutting-edge scientific technologies to Taiwan’s life science industry. We are dedicated to providing high-quality RUO products and personalized support through strong partnerships with innovative brands like Abcam, PacBio, Vizgen, Revvity, ibidi, Mirus Bio, Enzo Life Sciences, AnaSpec, Navinci Diagnostics, ScienCell, VWR, part of Avantor, BioChain, Eurogentec, Gene Tools, and Jena Bioscience . Our broad distribution channels across Taiwan ensure timely delivery, while our expert team offers tailored solutions to help customers achieve their research goals. We value customer feedback, aiming to build long-term partnerships and contribute to the growth of life science advancements in Taiwan, living up to our name—BLOSSOM.